Stay updated on SB8 vs Avastin in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the SB8 vs Avastin in Lung Cancer Clinical Trial page.

Latest updates to the SB8 vs Avastin in Lung Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content removal, particularly regarding a study on the biosimilarity of SB8 to bevacizumab for lung cancer treatment, including detailed study parameters and inclusion/exclusion criteria. The revision number has also been updated from v2.14.4 to v2.15.0.SummaryDifference6%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4 and removed a date reference of 2025-03-25 while adding a new date of 2024-12-16.SummaryDifference0.6%
- Check37 days agoChange DetectedThe page has been updated to reflect a new version (v2.14.3) and a new date for the results first posted, now set for March 25, 2025. The previous estimated dates and version have been removed.SummaryDifference0.5%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to SB8 vs Avastin in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SB8 vs Avastin in Lung Cancer Clinical Trial page.